Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
This comprehensive resource covers product change evaluation, postmarket surveillance, audit/inspection compliance, and various other laws and regulations pertaining to maintaining a product on the market.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization.
Stay informed on the latest healthcare regulatory news through RAPS’ online magazine, Regulatory Focus and its companion daily e-newsletter RF Today, or by following RAPS on social media, including Twitter, LinkedIn and Facebook.
Reporters, bloggers and other members of the media interested in covering RAPS events or programs should contact Nicole Duran, senior manager of communications, at nduran@raps.org or by calling +301 770 2920 ext. 245.
Posted 29 November 2022 | By Nicole Duran
The same community RAPS members have come to rely on, now with a sleeker look.
Posted 02 November 2022 | By Ryan Connors
These moves mark another step in RAPS’ mission to unite the global regulatory community in education, knowledge-sharing and career development. With the addition of Spain, RAPS now boasts 31 ...
Posted 19 October 2022 | By Ryan Connors
RAPS and Pathway for Patient Health have partnered to advance the preparedness of regulatory affairs professionals during an unparalleled time of rapid innovation and evolving expectations.
Posted 10 October 2022 | By Nicole Duran
RAPS congratulates the 82 professionals who earned their Regulatory Affairs Certification (RAC) during the summer examination window. The RAC credential is the leading certification for regula...
Posted 13 September 2022 | By Nicole Duran
The Regulatory Affairs Professionals Society (RAPS) concluded its annual RAPS Convergence in Phoenix on Tuesday, 13 September, attracting 1,700 participants from 41 countries across five conti...
Posted 09 May 2022 | By Ariana Pelosci
Investigators identified that in pivotal clinical trials supporting FDA approvals of CAR T-cell therapies for patients with hematologic cancer, Black patients were significantly underrepresented.
Posted 06 May 2022
Stakeholders in a session at MedCon 2022 expressed largely positive sentiments about their experience with the US Food and Drug Administration’s (FDA) Digital Health Software Precertification (Pre-Cert) Program.
Posted 05 May 2022 | By Shawn M. Schmitt
The draft document from the US agency looks to officially recognize a program aimed at advancing quality in medical devices and their manufacturing.
Posted 12 April 2022 | By Alan Condon
The FDA has issued two guidelines that make it less complex for medtech companies to commercialize orthopedic devices and sutures using its safety and performance-based pathway, according to the Regulatory Affairs Professionals Society.